Direkt zum Inhalt

Lordick, F ; Luber, B ; Lorenzen, S ; Hegewisch-Becker, S ; Folprecht, G ; Wöll, E ; Decker, T ; Endlicher, E ; Röthling, N ; Schuster, T ; Keller, G ; Fend, F ; Peschel, C

Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Article

Lordick, F, Luber, B, Lorenzen, S, Hegewisch-Becker, S, Folprecht, G , Wöll, E, Decker, T, Endlicher, E, Röthling, N, Schuster, T, Keller, G, Fend, F and Peschel, C (2010) Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). British Journal of Cancer 102 (3), pp. 500-505.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleBritish Journal of Cancer
PublisherNATURE PUBLISHING GROUP
Place of PublicationLONDON
Volume102
Number of Issue or Book Chapter3
Page Rangepp. 500-505
Date2010
Date of publication19 Dec 2024 11:40
InstitutionsMedicine > Lehrstuhl für Innere Medizin I
Identification Number
ValueType
10.1038/sj.bjc.6605521DOI
KeywordsCOLORECTAL-CANCER; GASTROESOPHAGEAL JUNCTION; FOLINIC ACID; K-RAS; INFUSIONAL FLUOROURACIL; CISPLATIN; ADENOCARCINOMA; MUTATIONS; THERAPY; TRIAL; antibody; chemotherapy; cetuximab; EGFR; gastric cancer; KRAS mutation
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID66386

Export bibliographical data

Owner only: item control page

nach oben